Widely used:Recently Viewed
Clear All$23.90
$1.22
(5.38%)
As on 24-Jun-2025 16:10EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$20,692 Mln
Revenue (TTM)
$17,980 Mln
Net Profit (TTM)
$0 Mln
ROE
0 %
ROCE
-- %
P/E Ratio
74.3
P/B Ratio
1.5
Industry P/E
61.46
EV/EBITDA
8.7
Div. Yield
4.3 %
Debt to Equity
0.6
Book Value
$--
EPS
$0.4
Face value
--
Shares outstanding
925,084,032
CFO
€16,424.00 Mln
EBITDA
€23,838.00 Mln
Net Profit
€6,138.00 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Koninklijke Philips N.V. NY Registry Shares - ADR
| -5.6 | 6.0 | -6.2 | -9.0 | 5.0 | -12.8 | -1.1 |
|
BSE Sensex*
| 5.5 | 1.1 | 5.9 | 6.8 | 16.1 | 18.8 | 11.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Koninklijke Philips N.V. NY Registry Shares - ADR
| 8.5 | 55.6 | -59.3 | -30.8 | 15.8 | 42.2 | -4.9 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic... imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral CT solutions; ultrasound imaging solutions focused on diagnosis, treatment planning and guidance for cardiac, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional X-ray systems and software solutions; and interventional image devices and software to aid in the diagnosis, navigation, treatment, and confirmation in minimally invasive interventional coronary, peripheral vascular, and hearth rhythm management procedures. The company also offers acute patient management solutions; emergency care solutions; patient care management in ambulatory and home care; sleep and respiratory care solutions; and vendor-agnostic software solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental and women's health solutions; and grooming and beauty products and solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands. Address: Philips Center, Amsterdam, Netherlands, 1096 BC Read more
President, CEO & Chairman of the Board of Management
Mr. Roy Jakobs
President, CEO & Chairman of the Board of Management
Mr. Roy Jakobs
Headquarters
Amsterdam
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Koninklijke Philips NV NY Registry Shares - ADR stood at $ 33,924 Mln as on 31-Mar-25
The share price of Koninklijke Philips NV NY Registry Shares - ADR is $23.90 (NYSE) as of 24-Jun-2025 16:10 EDT. Koninklijke Philips NV NY Registry Shares - ADR has given a return of 5.03% in the last 3 years.
Koninklijke Philips NV NY Registry Shares - ADR has a market capitalisation of $ 20,692 Mln as on 23-Jun-2025. As per Value Research classification, it is a company.
The P/B ratio of Koninklijke Philips NV NY Registry Shares - ADR is 1.54 times as on 23-Jun-2025, a 56% discount to its peers’ median range of 3.47 times.
The P/E ratio of Koninklijke Philips NV NY Registry Shares - ADR is 74.30 times as on 23-Jun-2025, a 21% premium to its peers’ median range of 61.46 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Koninklijke Philips NV NY Registry Shares - ADR and enter the required number of quantities and click on buy to purchase the shares of Koninklijke Philips NV NY Registry Shares - ADR.
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral CT solutions; ultrasound imaging solutions focused on diagnosis, treatment planning and guidance for cardiac, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional X-ray systems and software solutions; and interventional image devices and software to aid in the diagnosis, navigation, treatment, and confirmation in minimally invasive interventional coronary, peripheral vascular, and hearth rhythm management procedures. The company also offers acute patient management solutions; emergency care solutions; patient care management in ambulatory and home care; sleep and respiratory care solutions; and vendor-agnostic software solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental and women's health solutions; and grooming and beauty products and solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands. Address: Philips Center, Amsterdam, Netherlands, 1096 BC
The CEO & director of Mr. Roy Jakobs. is Koninklijke Philips NV NY Registry Shares - ADR, and CFO & Sr. VP is Mr. Roy Jakobs.
There is no promoter pledging in Koninklijke Philips NV NY Registry Shares - ADR.
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|
| Koninklijke Philips N.V. NY Registry Shares - ADR | Ratios |
|---|---|
|
Return on equity(%)
|
3.17
|
|
Operating margin(%)
|
6.37
|
|
Net Margin(%)
|
2.07
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Koninklijke Philips NV NY Registry Shares - ADR was $0 Mln.
